SAMH
VNDA icon

Shanda Asset Management Holdings’s Vanda Pharmaceuticals VNDA Stock Holding History

Shanda Asset Management Holdings’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-44,787
Closed -$631K – 41
2019
Q2 		$631K Hold
44,787
– – 0.12% 22
2019
Q1 		$824K Hold
44,787
– – 0.13% 40
2018
Q4 		$1.17M Hold
44,787
– – 0.22% 32
2018
Q3 		$1.03M Hold
44,787
– – 0.17% 25
2018
Q2 		$853K Hold
44,787
– – 0.13% 40
2018
Q1 		$755K Hold
44,787
– – 0.12% 29
2017
Q4 		$681K Buy
+44,787
New +$665K 0.1% 34

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Shanda Asset Management Holdings's VNDA Position: Q3 2019 in Review

Shanda Asset Management Holdings sold out of Vanda Pharmaceuticals (VNDA) in Q3 2019, closing a stake of 44,787 shares — an estimated $631K sold.

Shanda Asset Management Holdings first reported a position in VNDA in Q4 2017 and held it in 7 quarters. The position peaked at $1.17M in Q4 2018. 168 funds tracked by Wall St. Rank hold VNDA as of Q3 2019.

  • Shanda Asset Management Holdings reported no remaining Vanda Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 44,787 Vanda Pharmaceuticals shares in Q3 2019, an estimated $631K.
  • Shanda Asset Management Holdings first reported a position in Vanda Pharmaceuticals in Q4 2017 and held it in 7 quarters.
  • Shanda Asset Management Holdings's Vanda Pharmaceuticals position peaked at $1.17M in Q4 2018.
  • 168 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2019.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.